News >

Symptom Management, Risk Stratification Crucial in MPN Treatment

Kristi Rosa
Published: Tuesday, Jul 09, 2019

James M. Rossetti, DO

James M. Rossetti, DO

When it comes to the treatment of patients with myeloproliferative neoplasms (MPNs), assessing for potential disease-related symptoms is key, said James M. Rossetti, DO. Moreover, risk stratification in all of the diseases as it relates to blood cancer is of the utmost importance in order to identify who may require more aggressive therapy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x